<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Yoval-Sanchez B</submitter><funding>American Heart Association</funding><funding>Bundesministerium für Bildung und Forschung</funding><funding>Deutsche Forschungsgemeinschaft</funding><funding>NHLBI NIH HHS</funding><funding>NINDS NIH HHS</funding><funding>National Institutes of Health</funding><funding>NIH HHS</funding><pagination>102258</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8861397</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>51</volume><pubmed_abstract>Pathologies associated with tissue ischemia/reperfusion (I/R) in highly metabolizing organs such as the brain and heart are leading causes of death and disability in humans. Molecular mechanisms underlying mitochondrial dysfunction during acute injury in I/R are tissue-specific, but their details are not completely understood. A metabolic shift and accumulation of substrates of reverse electron transfer (RET) such as succinate are observed in tissue ischemia, making mitochondrial complex I of the respiratory chain (NADH:ubiquinone oxidoreductase) the most vulnerable enzyme to the following reperfusion. It has been shown that brain complex I is predisposed to losing its flavin mononucleotide (FMN) cofactor when maintained in the reduced state in conditions of RET both in vitro and in vivo. </pubmed_abstract><journal>Redox biology</journal><pubmed_title>Redox-dependent loss of flavin by mitochondria complex I is different in brain and heart.</pubmed_title><pmcid>PMC8861397</pmcid><funding_grant_id>SFB815/Z1</funding_grant_id><funding_grant_id>834220</funding_grant_id><funding_grant_id>R01 NS112381</funding_grant_id><funding_grant_id>R01HL132918</funding_grant_id><funding_grant_id>R01 HL132918</funding_grant_id><funding_grant_id>R01 HL151447</funding_grant_id><funding_grant_id>R01 NS100850</funding_grant_id><funding_grant_id>R01HL151447</funding_grant_id><funding_grant_id>NS100850</funding_grant_id><funding_grant_id>RO1NS112381</funding_grant_id><funding_grant_id>S10 OD030335</funding_grant_id><pubmed_authors>Sosunov S</pubmed_authors><pubmed_authors>Wittig I</pubmed_authors><pubmed_authors>Yoval-Sanchez B</pubmed_authors><pubmed_authors>Tikhonova IG</pubmed_authors><pubmed_authors>Ansari F</pubmed_authors><pubmed_authors>Filipenko P</pubmed_authors><pubmed_authors>James J</pubmed_authors><pubmed_authors>Ten V</pubmed_authors><pubmed_authors>Rafikov R</pubmed_authors><pubmed_authors>Niatsetskaya Z</pubmed_authors><pubmed_authors>Galkin A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Redox-dependent loss of flavin by mitochondria complex I is different in brain and heart.</name><description>Pathologies associated with tissue ischemia/reperfusion (I/R) in highly metabolizing organs such as the brain and heart are leading causes of death and disability in humans. Molecular mechanisms underlying mitochondrial dysfunction during acute injury in I/R are tissue-specific, but their details are not completely understood. A metabolic shift and accumulation of substrates of reverse electron transfer (RET) such as succinate are observed in tissue ischemia, making mitochondrial complex I of the respiratory chain (NADH:ubiquinone oxidoreductase) the most vulnerable enzyme to the following reperfusion. It has been shown that brain complex I is predisposed to losing its flavin mononucleotide (FMN) cofactor when maintained in the reduced state in conditions of RET both in vitro and in vivo. </description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 May</publication><modification>2026-04-08T08:25:16.516Z</modification><creation>2025-02-19T03:26:18.909Z</creation></dates><accession>S-EPMC8861397</accession><cross_references><pubmed>35189550</pubmed><doi>10.1016/j.redox.2022.102258</doi></cross_references></HashMap>